Silexion therapeutics to present at the noble capital markets 20th annual emerging growth equity conference

Grand cayman, cayman islands, silexion therapeutics corp. (nasdaq: slxn) (“silexion” or the “company”), a clinical-stage biotech developing rna interference (rnai) therapies for kras-driven cancers, today announced that the company's management will be attending and presenting at the noble capital markets 20th annual emerging growth equity conference taking place december 3-4, 2024, in boca raton, florida.
NE Ratings Summary
NE Quant Ranking